Abstract
BackgroundPrecise delivery of liquid embolic agents (LEAs) remains a challenge in the endovascular treatment of dural arteriovenous fistulae (dAVFs) and cerebral arteriovenous malformations (cAVMs). Despite significant advances in the past...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have